Adhering to the concept of "driving clinical transformation through cutting-edge basic research", the Clinical Medicine Institute is committed to building a clinical medical innovation highland that is based in Hangzhou, radiates across the country, and faces the world. Through mechanism innovation and disciplinary integration, it explores a new paradigm of "research-driven, clinical collaboration, and AI-enabled", creating a focused, inclusive, and long-term academic ecosystem to provide original innovative forces for conquering major diseases. It will implement an internationalized "physician-scientist" training model and PI responsibility system, relying on the rich clinical resources in the Yangtze River Delta, deeply integrating with multiple top hospitals, and building a rapid "clinical - basic - clinical" transformation channel from the end to the beginning, with a focus on cultivating medical leading talents and innovative teams with an international perspective.
Focusing on major chronic diseases that threaten human health, it prioritizes the layout of precision oncology and tumor immunotherapy, mechanisms and intervention strategies for heart and brain diseases, molecular networks and regulation of metabolic diseases, and AI-enabled bioinformatics, medical imaging, and innovative drug development. It focuses on closed-loop research from clinical problems to scientific discoveries, that is, closely integrated translational research and clinical research, including the discovery and validation of new biomarkers and therapeutic targets, disease prediction based on AI and big data, construction of diagnosis and treatment models, and cutting-edge treatment technologies etc.